Publication: Phenotypic characteristics of B cells in Behcet's disease: Increased activity in B cell subsets
| dc.contributor.authors | Eksioglu-Demiralp, E; Kibaroglu, A; Direskeneli, H; Yavuz, S; Karsli, F; Yurdakul, S; Yazici, H; Akoglu, T | |
| dc.date.accessioned | 2022-03-12T17:01:40Z | |
| dc.date.accessioned | 2026-01-11T08:38:26Z | |
| dc.date.available | 2022-03-12T17:01:40Z | |
| dc.date.issued | 1999 | |
| dc.description.abstract | Objective. Increased numbers of spontaneous Ig secreting B cells and elevated immunoglobulin levels have been described in Behcet's disease (BD), in addition to changes in numbers and activities of T cells, natural killer cells, and monocyte-macrophages. We investigated other characteristics of B cells in BD. Methods. B lymphocyte subsets (CD19+CD5+, CD19+CD13+, CD19+CD28+, CD19+CD33+, CD19+CD80+, CD5+CD19+CD45RA+, CD5+CD19+CD45RO+) were phenotypically evaluated in 50 patients with ED, 80 healthy subjects, and 20 other patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE); and sepsis. Results. Although the B cell number (CD19+) was normal, CD13 and CD33 positive B cells were more numerous in ED and sepsis compared to healthy controls and patients with RA and SLE. The percentage of CD45RO positive B cells was higher in both ED and sepsis, while the percentage of CD80 positive B cells was high only in ED. There was no increase in the CD5+CD19+ B cell subset, previously shown to be increased in several autoimmune diseases. Naive (CD45RA) and memory (CD45RO) status of CD5+CD19+ and CD5-CD19+ B cells showed that CD45RA expression was higher in CD5+CD19+ B cells, whereas expression of both CD45RA and CD45RO was higher in the CD5-CD19+ B cell group compared with healthy controls. Conclusion. Although the total B cell number was normal, increased levels of activated and memory B cell subsets suggest a modified B cell function in BI, which may be related to a weak stimulus by an unknown external antigen. | |
| dc.identifier.doi | doiWOS:000079667000012 | |
| dc.identifier.issn | 0315-162X | |
| dc.identifier.pubmed | 10229403 | |
| dc.identifier.uri | https://hdl.handle.net/11424/227401 | |
| dc.identifier.wos | WOS:000079667000012 | |
| dc.language.iso | eng | |
| dc.publisher | J RHEUMATOL PUBL CO | |
| dc.relation.ispartof | JOURNAL OF RHEUMATOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Behcet's disease | |
| dc.subject | CD5+B lymphocytes | |
| dc.subject | CD45RO | |
| dc.subject | CD45RA | |
| dc.subject | B-1 CELLS | |
| dc.subject | SUPEROXIDE GENERATION | |
| dc.subject | T-CELLS | |
| dc.subject | ANTIGEN | |
| dc.subject | BLOOD | |
| dc.subject | EXPRESSION | |
| dc.subject | LEUKEMIA | |
| dc.subject | CD5 | |
| dc.subject | DIFFERENTIATION | |
| dc.subject | INVOLVEMENT | |
| dc.title | Phenotypic characteristics of B cells in Behcet's disease: Increased activity in B cell subsets | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 832 | |
| oaire.citation.issue | 4 | |
| oaire.citation.startPage | 826 | |
| oaire.citation.title | JOURNAL OF RHEUMATOLOGY | |
| oaire.citation.volume | 26 |
